Behind the Scenes of the Human Breast Cell Atlas Project.
Behind the Scenes of the Human Breast Cell Atlas Project.
复制标题
DOI:
10.1007/s10911-021-09482-7
复制
发表时间:
2021-03
影响因子:
2.5
通讯作者:
van Amerongen R
中科院分区:
文献类型:
--
作者:
van Amerongen R
With the human genome project out of the way [1, 2] and the task of identifying all functional elements in our DNA bestowed upon the ENCODE consortium [3], scientists must have felt they were ready for the next big challenge: that of drafting a magna carta of the human body–and with single cell resolution at that. This is precisely what the Human Cell Atlas project aims to do. The overarching goal of the international consortium effort, backed by the Chan Zuckerberg Initiative (CZI) in the US, Horizon2020 in the EU and Wellcome in the UK, is to generate a collection of “cellular reference maps”, which will not only serve to catalogue the thousands of different cell types present in the human body, but which should also reveal cell state transitions, differentiation trajectories and lineage relationships. I will confess that as someone not (yet) directly involved in the effort, it was not all that clear to me how things were progressing. In particular, I found it difficult to get a proper idea of the status of the Human Breast Cell Atlas, with scarce information seemingly limited to the CZI website. To increase visibility and interest in the project, which could be a game changer in our field, I therefore decided to use this special issue of the Journal of Mammary Gland Biology and Neoplasia as an excuse to contact some of the lead scientists involved in these pioneering stages. Luckily, they were more than willing to give me a behind the scenes glimpse of the past, present and future of the Human Breast Cell Atlas. Following the launch of the Human Cell Atlas (HCA) at a kick-off meeting in London in October 2016, a white paper laid out its ambition and scope, emphasizing the need for standardization of experimental and computational methods [4]. The breast was notoriously absent from the initial list of biological systems presented by the founding consortium (as were other reproductive tissues), but this was to change a couple of months later, when Kai Kessenbrock (University of California, Irvine), Devon Lawson (University of California, Irvine), and Nicholas Navin (University of Texas MD Anderson Cancer Center) met at an HCA General Meeting, held at Stanford University in February 2017. Here, CZI introduced the project, its organization as a scientist-led con-
影响因子:
64.8
作者:
Snyder, Michael P.;Gingeras, Thomas R.;Myers, Richard M.
通讯作者:
Myers, Richard M.
影响因子:
16.6
作者:
Bach K;Pensa S;Grzelak M;Hadfield J;Adams DJ;Marioni JC;Khaled WT
通讯作者:
Khaled WT
影响因子:
3.8
作者:
Degnim, Amy C.;Visscher, Daniel W.;Hartmann, Lynn C.
通讯作者:
Hartmann, Lynn C.